Purpose: To determine the prevalence of refractive errors, among 6- to 15-year-old schoolchildren in the city of Dezful in western Iran.
Methods: In this cross-sectional study, 1375 Dezful schoolchildren were selected through multistage cluster sampling. After obtaining written consent, participants had uncorrected and corrected visual acuity tests and cycloplegic refraction at the school site. Refractive errors were defined as myopia [spherical equivalent (SE) -0.5 diopter (D)], hyperopia (SE ≥ 2.0D), and astigmatism (cylinder error > 0.5D).
Results: 1151 (83.7%) schoolchildren participated in the study. Of these, 1130 completed their examinations. 21 individuals were excluded because of poor cooperation and contraindication for cycloplegic refraction. Prevalence of myopia, hyperopia, and astigmatism were 14.9% (95% confidence interval (CI): 10.1-19.6), 12.9% (95% CI: 7.2-18.6), and 45.3% (95% CI: 40.3-50.3), respectively. Multiple logistic regression analysis showed an age-related increase in myopia prevalence (p << 0.001) and a decrease in hyperopia prevalence (p << 0.001). There was a higher prevalence of myopia in boys (p<<0.001) and hyperopia in girls (p = 0.007).
Conclusion: This study showed a considerably high prevalence of refractive errors among the Iranian population of schoolchildren in Dezful in the west of Iran. The prevalence of myopia is considerably high compared to previous studies in Iran and increases with age.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4877718 | PMC |
http://dx.doi.org/10.1016/j.joco.2015.09.008 | DOI Listing |
Sci Rep
January 2025
College of Health Sciences, Department of Optometry, University of KwaZulu-Natal, Durban, South Africa.
The global burden of uncorrected refractive error demands for adoption of different approaches inclined towards scaling effective refractive error coverage. While innovative approaches such as utilization of telemedicine is being adopted by social enterprises in different parts of the world to scale refractive error service delivery, commercial entrepreneurship still dominates the optical industry in Kenya with minimal focus on accessibility and affordability. However, to achieve effective refractive error coverage across the economic pyramid, integration of enterprises inclined towards fulfilling a social mission through innovative approaches such as telemedicine is desirable.
View Article and Find Full Text PDFPurpose: To evaluate the clinical outcome of laser-assisted surgical correction of high hyperopic or mixed astigmatism using small incision intrastromal lenticule rotation (SMILERO) alone or combined with photorefractive keratectomy (PRK).
Methods: This retrospective case series enrolled 25 eyes with high astigmatism that underwent SMILERO surgery. Uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), uncorrected near visual acuity (UNVA), manifest refraction, central corneal thickness, and corneal higher order aberrations were analyzed before surgery and after 3, 6, and 12 months of follow-up.
Purpose: To evaluate a new regression-derived nomogram for high myopic astigmatism in small incision lenticule extraction (SMILE) surgery.
Methods: In this prospective study, data from 180 eyes with myopic astigmatism ranging from -2.50 to -4.
Purpose: To evaluate dynamic changes in ciliary parameters and Implantable Collamer Lens V4C (ICL) (STAAR Surgical) haptic position using mydriatic and miotic agents and their effects on the central and peripheral vault.
Methods: This study involved 80 eyes from 40 consecutive patients (mean age: 28.05 years; range: 19 to 42 years) examined 3 months after ICL implantation.
Purpose: To compare the clinical outcomes, surgical workflow, and patient satisfaction following small incision lenticule extraction (SMILE) performed with the VisuMax 800 in one eye and the VisuMax 500 in the contralateral eye (both Carl Zeiss Meditec).
Methods: This was a prospective, single-site clinical study of patients undergoing SMILE for myopia and myopic astigmatism between February 2022 and August 2023. Each patient underwent bilateral treatment using the VisuMax 800 (VM800 group) in one eye and the VisuMax 500 (VM500 group) in the contralateral eye.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!